HollisterStier Named Manufacturer of the Year
Published September 22, 2010
"HollisterStier has a deliberate set of systems and processes aimed at client satisfaction, employee engagement and empowerment and activity optimization. In meeting these three goals, our organization lends itself to continued quality innovation and improvement, corporate responsibility and workforce excellence. Our selection for this award is a testament to not only our successes in the highly complex industry of pharmaceutical manufacturing, but to the great employees we have here at HollisterStier -- this honor would not be possible without their hard work and dedication" said Marcelo Morales, Chief Executive Officer, HollisterStier Laboratories.
About HollisterStier Contract Manufacturing
HollisterStier Contract Manufacturing is a global manufacturing service provider, able to aseptically fill liquid and lyophilized products at our Spokane, Washington facility and semi-solid and solid dosage forms at our sister organizations located in Canada, the United States and India. HollisterStier Contract Manufacturing offers highly-skilled, cross-functional teams to provide custom solutions to customer-specific project goals from development through commercialization. Along with our manufacturing partners, we are committed to providing exceptional quality, regulatory expertise and operational excellence to ensure streamlined processes and services in all facilities. For more information about HollisterStier Contract Manufacturing as well as our parent and sister companies, please visit HScontract.com.
Jubilant Organosys Ltd., an integrated pharmaceutical industry player, is the largest custom research and manufacturing services (CRAMS) Company out of India. The company has a presence across the pharmaceutical value chain for providing products and services such as proprietary products, exclusive synthesis, active pharmaceutical ingredients, contract manufacturing of sterile injectables & non-steriles products, radiopharmaceuticals, generic dosage forms, drug discovery services, medicinal chemistry services, clinical research services, Life Science Chemicals, Nutrition Ingredients and Health Care. The Company also manufactures Agri and Performance Polymer products.
Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential product characteristics and uses, product sales potential and target dates for product launch are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Jubilant Organosys and its subsidiaries may, from time to time, make additional written and oral forward looking statements, including statements contained in the Company's filings with the regulatory bodies and its reports to shareholders. The Company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.
blog comments powered by Disqus